Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy

Circulation

Volumn 96, Issue 2, 1997, Pages 542-549

  Müller, Johannes ^a   Wallukat, Gerd ^b   Weng, Yu Guo ^a   Dandel, Michael ^a   Spiegelsberger, Susanne ^a   Semrau, Sabine ^a   Brandes, Kersten ^a   Theodoridis, Vassilis ^a   Loebe, Matthias ^a   Meyer, Rudolf ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Assist devices; Cardiomyopathy; Implantation

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; RECEPTOR ANTIBODY;

ADULT; AGED; ARTICLE; ASSISTED CIRCULATION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART VOLUME; HEART WORK; HUMAN; HUMAN TISSUE; IMPLANTATION; MALE; PRIORITY JOURNAL; WEANING;

EID: 0343765713     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.2.542     Document Type: Article

References (50)

1. Mehta SM, Aufiero TX, Pae WE Jr, Miller CA, Pierce WS. Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation: sixth official report - 1994. J Heart Lung Transplant. 1995;14:584-593.
2. Pae WE Jr. Ventricular assist devices and total artificial hearts: a combined registry experience. Ann Thorac Surg. 1993;55:295-298.
3. Hetzer R, Hennig E, Schiessler A, Friedel N, Warnecke H, Adt M. Mechanical circulatory support and heart transplantation. J Heart Lung Transplant. 1992;11:S175-S181.
4. Magovern GL, Golding LA, Oyer PE, Cabrol C. Circulatory support - 1988: weaning and bridging. Ann Thorac Surg. 1989;47: 102-107.
5. Pae WE Jr, Miller CA, Matthews Y, Pierce WS. Ventricular assist devices for postcardiotomy cardiogcnic shock: a combined registry experience. J Thorac Cardiavasc Surg. 1992;104:541-553.
6. Holman WL, Bourge RC, Kirklin JK. Case report: circulatory support for seventy days with resolution of acute heart failure. J Thorac Cardiovasc Surg. 1991;102:932-934.
7. Portner PM. A totally implantable heart assist system: the Novacor program. In: Akutsu T, Koyanagi H, eds. Heart Replacement: Artificial Heart 4. Tokyo, Japan: Springer-Verlag; 1993:71-82.
8. Noon GP. Clinical use of cardiac assist devices. In: Akutzu T, Koyanagi H, eds. Heart Replacement: Artificial Heart 4. Tokyo, Japan: Springer-Verlag; 1993:195-205.
9. Nakatani T, Sasako Y, Kumon K, Nagata S, Kosakai Y, Isobe F, Nakano K, Kobayashi J, Eishi K, Takano H, Kito Y, Kawashima Y. Long-term circulatory support to promote recovery from pro found heart failure. ASAIO J. 1995;41:M526-M530.
10. Levin HR, Oz MC, Catancse KA, Rose EA, Burkhoff D. Transient normalisation of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant. 1996;15:840-842.
11. McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg. 1995;59:609-613.
12. Levin HR. Invited commentary to: McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg. 1995;59:609-613.
13. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilatation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 1995;91:2717-2720.
14. Frazier OH, Benedect CR, Radovancevic B, Bick RJ, Capek P, Springer WE, Macris MP, Delgado R, Buja M. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996;62:675-682.
15. Krehl L. Beitrag zur Kenntnis der idiopathischen Herzmuskelerkrankung. Deutsch Arch F Klin Med. 1891;48:414-431.
16. Abelmann WH. Myocarditis as a cause of dilated cardiomyopathy. In: Engelmeier BS, O'Connel JB, eds. Dnig Therapy in Dilated Cardiomyopathy and Myocarditis. New York, NY: Marcel Dekker; 1988:221-231.
17. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994;331:1564-1575.
18. Maisch B, Berg PA, Kochsiek K. Immunological parameters in patients congestive cardiomyopathy. Basic Res Cardiol. 1980;75: 221-222.
19. Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol. 1983;52:1072-1078.
20. Schultheiss H-P. The significance of autoantibodies against ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy: clinical and experimental data. Springer Semin Immunopathol. 1989;11:15-30.
21. Schultheiss H-P. Disturbance of the myocardial energy metabolism in dilated cardiomyopathy due to autoimmunological mechanisms. Circulation. 1993;87(suppl IV):IV-43-IV-48.
22. Caforio AL, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF, McKenna WJ. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol. 1990;15: 1527-1534.
23. Wallukat G, Wollenberger A. Effects of serum gamma globulin fractions of patients with allergic asthma and dilated cardiomyopathy on chronotropic β-adrenoceptor function in cultured neonatal rat heart myocytes. Biomed Biochim Acta. 1987;46:634-639.
24. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against beta-adrenoceptors in human dilated cardiomyopathy. Circ Res. 1989; 64:97-103.
25. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson Å, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy: characterization of antibodies against the β1-adrenoceptor with positive chronotropic effect. Circulation. 1994;89:2760-2767.
26. Wallukat G, Morwinski R, Magnusson Y, Hoebeke J, Wollenberger A. Autoantikörper gegen den β1-adrenergen Rezeptor bei Myokarditis und dilatativer Kardiomyopathie: Lokalisation von zwei Epitopen. Z Kardiol. 1992;81(suppl 4):79-83.
27. Ansari AA, Neckelmann N, Wang Y-C, Gravenis MC, Sell KW, Herskowitz A. Immunologic dialogue between cardiac myocytes, endothelial cells and mononuclear cells. Clin Immunol Immunopathol. 1993;68:208-214.
28. Taha TH, Mazelka P, Oakley CM, Maisch B. Cardiac-specific antibodies in dilated cardiomyopathy. J Am Coll Cardiol. 1991;18: 644-645.
29. Rose NR, Beisel KW, Herskowitz A. Cardiac myosin and autoimmune myocarditis. Ciba Found Sympos. 1987;129:3-24.
30. Wolff PG, Schulteis H-P. Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J. 1989;117(6):1303-1309.
31. Borda ES, Pascual J, Cossio PM, Vega M, Arana RM, Sterin-Borda L. Circulating IgG in chagas disease which binds to β-adrenoceptor of myocardium and modulates its activity. Clin Exp Immunol. 1984; 57:679-686.
32. Tayama E, Nose Y. Can we treat dilated cardiomyopathy using a left ventricular assist device? Artif Organs. 1996;20:197-201. Editorial.
33. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th ed. In: Dolgin M. ed. Boston, Mass: Little, Brown and Co; 1994:240.
34. Pennington DG, McBride LR, Swartz MT. Implantation technique for the Novacor left ventricular assist system. J Thorac Cardiovasc Surg. 1994;108:604-608.
35. Radovancevic B, Frazier OH, Michael JM. Implantation technique for the HeartMate left ventricular assist device. J Card Surg. 1992; 7(3):203-207.
36. Wallukat G, Wollenberger A. Die kultivierte Herzmuskelzelle. Ein funktionelles Testsystem zum Nachweis von Autoantikörpern gegen den β-adrenergen Rezeptor. Acta Histochem. 1988:(suppl XXXV);145-149.
37. Weibel ER, Kistler GS, Scherle WF. Practical stereological methods for morphometric cytology. J Cell Biol. 1966;30:23-38.
38. Burch GE. On resting the human heart. Am Heart J. 1966;71:422.
39. Burch GE, McDonald CD, Walsh JJ. The effect of prolonged bed rest on postpartal cardiomyopathy. Am Heart J. 1971;81:186-201.
40. Ansari AA, Wang Y-C, Danner DJ, Gravanis MB, Mayne A, Neckelmann N, Sell KW, Herskowitz A. Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy. Am J Pathol. 1991;139:337-354.
41. Maisch B, Wedekind U, Kochsick K. Quantitative assessment of antilaminin antibodies in myocarditis and perimyocarditis. Eur Heart J. 1987;8(suppl I):233-235.
42. Spinale FG, Zellner JL, Tomita M, Crawford FA, Zile MR. Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circ Res. 1991;69:1058-1067.
43. Spinale FG, Tomita M, Zellner JL, Cook JC, Crawford FA, Zile MR. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol. 1991;261(2 Pt 2):H308-H318.
44. Matsui S, Fu MLX, Katsuda S, Hayase M, Yamaguchi N, Teraoka K, Kurihara T, Takekoshi N, Murakami E, Hoebeke J, Hjalmarson A. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathy changes in immunized rabbits. JMCC. 1997; in press.
45. Hosenpud JD, Campbell SM, Niles NR, Lee J, Mendelson D, Hart MV. Exercise induced augmentation of cellular and humoral autoimmunity associated with increased cardiac dilatation in experimental autoimmune myocarditis. Cardiovasc Res. 1987;21:217-222.
46. Nakatani S, McCathy PM, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol. 1996;27: 894-901.
47. Scheinin SA, Capek P, Radovancevic B, Duncan JM, McAllister HA, Frazier OH. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J. 1992;38:M271-M274.
48. Kinoshita M, Takano H, Takaichi S, Taenaka Y, Nakatani T. Influence of prolonged ventricular assistance on myocardial histopathology in intact heart. Ann Thorac Surg. 1996;61:640-645.
49. Tomantek RJ, Cooper G. Morphological changes in the mechanically unloaded myocardial cell. Anal Record. 1981;200:271-280.
50. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E. Effect of the implantable assist ventricular device on neuroendocrine activation in heart failure. Circulation. 1995; 92(suppl II):II-191-II-195.